Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.

PLoS One · 2018 · PMC6053227 · PMID 30024982

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

reported that there was a decreasing trend of a positive rate of sputum smear in the MDR-TB patients receiving continuous daily rhuIL-2 therapy [ 18 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.